(Q40463031)

20 September 2017

Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen. (English)

1 reference

20 September 2017

1 reference

3

David A Flockhart

1 reference

20 September 2017

2

Zeruesenay Desta

1 reference

20 September 2017

Young Chai Lim

1

1 reference

20 September 2017

Todd C Skaar

series ordinal

4

1 reference

20 September 2017

language of work or name

1 reference

1 February 2005

1 reference

Cancer Chemotherapy and Pharmacology

20 September 2017

1 reference

20 September 2017

55

1 reference

20 September 2017

471-478

1 reference

20 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-004-0926-7

20 September 2017

0 references

cites work

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1007%2FS00280-004-0926-7

Crossref

reference URL

10.1007/S00280-004-0926-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference